Rockefeller Capital Management L.P. Acquires 5,760 Shares of Stryker Co. (NYSE:SYK)

Rockefeller Capital Management L.P. lifted its holdings in shares of Stryker Co. (NYSE:SYK - Free Report) by 10.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,324 shares of the medical technology company's stock after purchasing an additional 5,760 shares during the quarter. Rockefeller Capital Management L.P.'s holdings in Stryker were worth $21,720,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Petros Family Wealth LLC bought a new position in Stryker in the 4th quarter worth $1,589,000. NFP Retirement Inc. bought a new position in shares of Stryker in the fourth quarter worth about $205,000. Monetary Management Group Inc. lifted its position in shares of Stryker by 5.4% during the 4th quarter. Monetary Management Group Inc. now owns 7,638 shares of the medical technology company's stock worth $2,750,000 after purchasing an additional 393 shares during the last quarter. Oak Associates Ltd. OH boosted its stake in Stryker by 43.2% during the 4th quarter. Oak Associates Ltd. OH now owns 6,164 shares of the medical technology company's stock valued at $2,219,000 after purchasing an additional 1,860 shares during the period. Finally, First Foundation Advisors grew its holdings in Stryker by 6.2% in the 4th quarter. First Foundation Advisors now owns 804 shares of the medical technology company's stock valued at $289,000 after buying an additional 47 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company's stock.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 201,392 shares of the firm's stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the sale, the director now directly owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. This trade represents a 5.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Allan C. Golston sold 2,458 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the sale, the director now owns 14,895 shares in the company, valued at $5,705,827.65. This represents a 14.16 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is owned by company insiders.

Analyst Ratings Changes

SYK has been the topic of several research analyst reports. Citigroup restated a "buy" rating and issued a $450.00 price objective on shares of Stryker in a research note on Wednesday, February 26th. Barclays raised their price target on shares of Stryker from $418.00 to $443.00 and gave the stock an "overweight" rating in a research report on Monday, February 10th. Stifel Nicolaus increased their target price on shares of Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a research note on Wednesday, January 29th. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a report on Tuesday, February 18th. Finally, Royal Bank of Canada lifted their price objective on Stryker from $425.00 to $435.00 and gave the stock an "outperform" rating in a report on Wednesday, January 29th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $423.53.

Stryker Stock Down 0.1 %

NYSE:SYK traded down $0.21 during trading hours on Friday, reaching $346.46. 1,349,873 shares of the stock were exchanged, compared to its average volume of 1,357,726. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. Stryker Co. has a twelve month low of $314.93 and a twelve month high of $406.19. The stock has a market cap of $132.24 billion, a PE ratio of 44.65, a PEG ratio of 2.93 and a beta of 0.93. The firm has a 50 day moving average of $370.95 and a 200 day moving average of $373.31.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period last year, the company posted $3.46 EPS. On average, equities analysts expect that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Monday, March 31st. Stryker's dividend payout ratio is currently 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.